Oncologists Embrace Part B Demo, Amgen Says; Big Test In Two Months
The Medicare Part B market is holding up well in the early weeks of 2005 thanks to a $300 mil. demonstration project unveiled in November, Amgen told analysts Jan. 27 in New York
The Medicare Part B market is holding up well in the early weeks of 2005 thanks to a $300 mil. demonstration project unveiled in November, Amgen told analysts Jan. 27 in New York